These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38118411)

  • 21. NS6740, an α7 nicotinic acetylcholine receptor silent agonist, disrupts hippocampal synaptic plasticity.
    Papke RL; Peng C; Kumar A; Stokes C
    Neurosci Lett; 2018 Jun; 677():6-13. PubMed ID: 29679680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification by virtual screening and functional characterisation of novel positive and negative allosteric modulators of the α7 nicotinic acetylcholine receptor.
    Smelt CLC; Sanders VR; Newcombe J; Burt RP; Sheppard TD; Topf M; Millar NS
    Neuropharmacology; 2018 Sep; 139():194-204. PubMed ID: 30009834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Novel, Nicotinic Alpha7 Receptor Partial Agonist, BMS-933043, Improves Cognition and Sensory Processing in Preclinical Models of Schizophrenia.
    Bristow LJ; Easton AE; Li YW; Sivarao DV; Lidge R; Jones KM; Post-Munson D; Daly C; Lodge NJ; Gallagher L; Molski T; Pieschl R; Chen P; Hendricson A; Westphal R; Cook J; Iwuagwu C; Morgan D; Benitex Y; King D; Macor JE; Zaczek R; Olson R
    PLoS One; 2016; 11(7):e0159996. PubMed ID: 27467081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional alpha7 nicotinic receptors are expressed on immature granule cells of the postnatal dentate gyrus.
    John D; Shelukhina I; Yanagawa Y; Deuchars J; Henderson Z
    Brain Res; 2015 Mar; 1601():15-30. PubMed ID: 25553616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. (E)-3-furan-2-yl-N-phenylacrylamide (PAM-4) decreases nociception and emotional manifestations of neuropathic pain in mice by α7 nicotinic acetylcholine receptor potentiation.
    Bagdas D; Sevdar G; Gul Z; Younis R; Cavun S; Tae HS; Ortells MO; Arias HR; Gurun MS
    Neurol Res; 2021 Dec; 43(12):1056-1068. PubMed ID: 34281483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. α7 Nicotinic Acetylcholine Receptor: A Potential Target in Treating Cognitive Decline in Schizophrenia.
    Jones C
    J Clin Psychopharmacol; 2018 Jun; 38(3):247-249. PubMed ID: 29505470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. α7 nicotinic acetylcholine receptors control cytochrome c release from isolated mitochondria through kinase-mediated pathways.
    Gergalova G; Lykhmus O; Komisarenko S; Skok M
    Int J Biochem Cell Biol; 2014 Apr; 49():26-31. PubMed ID: 24412630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha7 nicotinic acetylcholine receptors and neural network synaptic transmission in human induced pluripotent stem cell-derived neurons.
    Larsen HM; Hansen SK; Mikkelsen JD; Hyttel P; Stummann TC
    Stem Cell Res; 2019 Dec; 41():101642. PubMed ID: 31707211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The selective nicotinic acetylcholine receptor alpha7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and pain.
    Feuerbach D; Lingenhoehl K; Olpe HR; Vassout A; Gentsch C; Chaperon F; Nozulak J; Enz A; Bilbe G; McAllister K; Hoyer D
    Neuropharmacology; 2009 Jan; 56(1):254-63. PubMed ID: 18793655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential Activation and Desensitization States Promoted by Noncanonical
    Stokes C; Camacho-Hernandez GA; Thakur GA; Wu X; Taylor P; Papke RL
    J Pharmacol Exp Ther; 2022 Nov; 383(2):157-171. PubMed ID: 36279397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin II Triggers Peripheral Macrophage-to-Sensory Neuron Redox Crosstalk to Elicit Pain.
    Shepherd AJ; Copits BA; Mickle AD; Karlsson P; Kadunganattil S; Haroutounian S; Tadinada SM; de Kloet AD; Valtcheva MV; McIlvried LA; Sheahan TD; Jain S; Ray PR; Usachev YM; Dussor G; Krause EG; Price TJ; Gereau RW; Mohapatra DP
    J Neurosci; 2018 Aug; 38(32):7032-7057. PubMed ID: 29976627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positive allosteric modulation of alpha-7 nicotinic receptors promotes cell death by inducing Ca(2+) release from the endoplasmic reticulum.
    Guerra-Álvarez M; Moreno-Ortega AJ; Navarro E; Fernández-Morales JC; Egea J; López MG; Cano-Abad MF
    J Neurochem; 2015 May; 133(3):309-19. PubMed ID: 25650007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on the role of alpha 7 nicotinic acetylcholine receptors in K562 cell proliferation and signaling.
    Önder Narin G; Aydın B; Cabadak H
    Mol Biol Rep; 2021 Jun; 48(6):5045-5055. PubMed ID: 34143396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of Mast Cells in α7 Nicotinic Receptor Agonist Exacerbation of Freund's Complete Adjuvant-Induced Monoarthritis in Mice.
    Lopes F; Graepel R; Reyes JL; Wang A; Petri B; McDougall JJ; Sharkey KA; McKay DM
    Arthritis Rheumatol; 2016 Feb; 68(2):542-52. PubMed ID: 26314943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The therapeutic potential of α7 nicotinic acetylcholine receptor (α7 nAChR) agonists for the treatment of the cognitive deficits associated with schizophrenia.
    Beinat C; Banister SD; Herrera M; Law V; Kassiou M
    CNS Drugs; 2015 Jul; 29(7):529-42. PubMed ID: 26242477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The structure-activity relationships of novel α7 nicotinic acetylcholine receptor agonists based on indolizine scaffold].
    Li Q; Yang TY; Xue Y; Ma XZ; Tang JS; Zhang GS; Wang KW; Zhang LR
    Yao Xue Xue Bao; 2016 Oct; 51(10):1584-94. PubMed ID: 29932605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CDP-choline and galantamine, a personalized α7 nicotinic acetylcholine receptor targeted treatment for the modulation of speech MMN indexed deviance detection in healthy volunteers: a pilot study.
    Choueiry J; Blais CM; Shah D; Smith D; Fisher D; Illivitsky V; Knott V
    Psychopharmacology (Berl); 2020 Dec; 237(12):3665-3687. PubMed ID: 32851421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. α7-nicotinic acetylcholine receptor agonists for cognitive enhancement in schizophrenia.
    Freedman R
    Annu Rev Med; 2014; 65():245-61. PubMed ID: 24111888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are positive allosteric modulators of α7 nAChRs clinically safe?
    Uteshev V
    J Neurochem; 2016 Jan; 136(2):217-9. PubMed ID: 26182952
    [No Abstract]   [Full Text] [Related]  

  • 40. An Evolving Therapeutic Rationale for Targeting the α
    Deutsch SI; Burket JA
    Curr Top Behav Neurosci; 2020; 45():167-208. PubMed ID: 32468495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.